CONCORD
Concord Drugs LimitedHealthcare
LTP
71.21
CHG · %
-2.19 (-2.98%)
VOL · TODAY
2.58K
PREV CLOSE
73.4
Today's range71.2 · 73
71.21
52-week range26.1 · 92.52
71.21
Loading candles…
Concord Drugs Ltd, incorporated in 1995, operates in the pharmaceutical industry in India. The company manufactures licensed drugs based on approved formulations and specializes in developing and producing drug delivery systems such as the Multiple Unit Pellet System (MUPS), sustained release, and modified release pellets. It provides contract manufacturing services covering the process from drug development to finished pharmaceutical formulations. Concord Drugs Ltd operates a WHO-GMP certified facility and focuses primarily on the pharmaceutical formulation segment. There are no public listings or subsidiaries associated with the company according to available information.
CONCORD is not part of any active scan today.
This page is a live market overview for Concord Drugs Limited (CONCORD) on the BSE. As a listed security, Concord Drugs Limited is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for CONCORD before placing trades on tick2trade.
As of the latest feed, CONCORD last traded at ₹71.21 on BSE, down ₹2.19 (2.98%) from the previous close of ₹73.4. Today's session range is ₹71.2 – ₹73, against a 52-week band of ₹26.1 – ₹92.52. Traded volume today stands at 2.58K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for CONCORD in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether CONCORD is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for Concord Drugs Limited before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in CONCORD. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated CONCORD option chain page linked from this overview.
// similar in healthcare314 total